Protocol summary

Summary
In this single center phase III clinical trial, 34 patients with diagnosis of chronic prostatitis/chronic pelvic pain syndrome (according to history and physical examination and urodynamic study) who are referred to Shohada-e-Tajrish urology clinic are enrolled. They are divided into two groups: the first group numbered 17 patients, who are treated with a combination of an a-blocker, an anti-inflammatory agent, a muscle relaxant and a short course of antibiotic treatment in combination with 4 sessions of perineal focused extracorporeal shockwave therapy (ESWT); the second group consist of 17 patients who receive a combination of sham-ESWT and the fore-mentioned triple therapy and short course of antibiotic. Patients and data analyzer are blind to data. Both groups are evaluated with NIH-CPSI, IPSS and IIEF5 questionnaires and uroflowmetry, at the beginning, 1 month and 3 months after treatment, and the results will be compared between both groups.

General information

Acronym
IRCT registration information
IRCT registration number: IRCT2017082635911N1
Registration date: 2017-11-17, 1396/08/26
Registration timing: registered_while_recruiting

Last update:
Update count: 0
Registration date
2017-11-17, 1396/08/26
Registrant information
Name
Farzad Allameh
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 21 2273 6386
Email address
farzadallameh@sbmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Shahid Beheshti University of Medical Sciences
Expected recruitment start date
2017-09-23, 1396/07/01
Expected recruitment end date
2018-01-05, 1396/10/15
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Assessment the effect of focused extracorporeal shockwave therapy in pain management, erectile dysfunction and urinary symptoms in patients suffering from chronic pelvic pain syndrome – a randomized clinical trial
Public title
Shock-wave therapy in men with pelvic pain
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria: >18 years old; definite diagnosis of CPPS; Symptomatic for at least 3 months; no treatment before; sign the informed consent Exclusion criteria: acute or chronic bacterial prostatitis; UTI in 1 recent year; history of prostate cancer or PSA>4; coagulation problems; history of hematuria, urethral stricture, urologic cancers, urolithiasis, neurogenic bladder, STDs, colorectal problems, inguinal hernia and varicocele; drug addiction
Age
From 18 years old
Gender
Male
Phase
3
Groups that have been masked
No information
Sample size
Target sample size: 34
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Double blinded
Blinding description
Placebo
Used
Assignment
Parallel
Other design features
Randomization method: closed envelopes

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethic committee of Shahid Beheshti University of Medical Sciences - School of Medicine
Street address
Arabi street, Daneshjoo Boulevard, Velenjak
City
Tehran
Postal code
Approval date
2017-05-30, 1396/03/09
Ethics committee reference number
IR.SBMU.MSP.REC.1396.158

Health conditions studied

1

Description of health condition studied
Chronic Pelvic Pain Syndrome (Chronic Prostatitis)
ICD-10 code
N41.1
ICD-10 code description
Chronic prostatitis

Primary outcomes

1

Description
Pain
Timepoint
before, 1 and 3 months after procedure
Method of measurement
Visual Analog Scale Questionnaire

2

Description
Qmax
Timepoint
before, 1 and 3 months after procedure
Method of measurement
Uroflowmetry

3

Description
Erectile Dysfunction
Timepoint
before, 1 and 3 months after procedure
Method of measurement
International Index of Erectile Function 5 Questionnaire

4

Description
Symptoms Severity
Timepoint
before, 1 and 3 months after procedure
Method of measurement
National Institute of Health Chronic Prostatitis Index Questionnaire

5

Description
Lower urinary Tract Symptoms
Timepoint
before, 1 and 3 months after procedure
Method of measurement
International Prostate Symptom Score Questionnaire

Secondary outcomes

1

Description
Hematuria
Timepoint
1 and 3 months after procedure
Method of measurement
Inreview

2

Description
Hematospermia
Timepoint
1 and 3 months after procedure
Method of measurement
Interview

3

Description
Post void residue
Timepoint
before, 1 and 3 months after
Method of measurement
uroflowmetry

Intervention groups

1

Description
Intervention : Cap tamsolusin (Abidi Co) 0.4 mg qhs 3 months Tab Alfen XL (Abidi Co) 100 mg Daily for 3 months Tab Baclofen (Abidi Co) 10 mg BD for 3 months Tab ofloxacin (Abidi Co) 300 BD for 2 weeks 4 sessions of perineal focused ESWT (STORZ Co) Weekly
Category
Treatment - Drugs

2

Description
Control : Cap Tamsolusin (Abidi Co) 0.4 mg qhs for 3 months Tab Alfen XL (Abidi Co) 100 mg Daily for 3 month Tab Baclofen (Abidi Co) 10 mg BD for 3 months Tab Ofloxacin (Abidi Co) 300 mg BD for 2 weeks 4 sessions of perineal Sham ESWT (STORZ Co) Weekly
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Shohada-e-Tajrish Hospital
Full name of responsible person
Farzad Allameh
Street address
Tajrish Square
City
Tehran

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Vice chancellor for research, Shahid Beheshti University of Medical Sciences
Full name of responsible person
Ms Mehrnoush Moinfard
Street address
Shohada-e-Tajrish Hospital, Tajrish Square
City
Tehran
Grant name
Grant code / Reference number
-
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Vice chancellor for research, Shahid Beheshti University of Medical Sciences
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty

Person responsible for general inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Farzad Allameh
Position
Assistant Professor
Other areas of specialty/work
Street address
Shohada-e-Tajrish Hospital, Tajrish Square
City
Tehran
Postal code
Phone
+98 21 2273 6386
Fax
Email
farzadallame@gmail.com
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Farzad Allameh
Position
MD-MPH Urologist
Other areas of specialty/work
Street address
Shohada-e-Tajrish Hospital
City
Tehran
Postal code
Phone
+98 21 2273 6386
Fax
Email
farzadallame@gmail.com
Web page address

Person responsible for updating data

Contact
Name of organization / entity
Shahid Beheshti University of Medical Sciences
Full name of responsible person
Farzad Allameh
Position
Other areas of specialty/work
Street address
City
Postal code
Phone
+98 21 2280 4301
Fax
Email
farzadallame@gmail.com
Web page address

Sharing plan

Deidentified Individual Participant Data Set (IPD)
empty
Study Protocol
empty
Statistical Analysis Plan
empty
Informed Consent Form
empty
Clinical Study Report
empty
Analytic Code
empty
Data Dictionary
empty
Loading...